Bristol Myers Squibb’s cell therapy gets USFDA nod for relapsed or refractory follicular lymphoma Read more
Anticipation builds as Insmed bronchiectasis therapy brensocatib nears Phase III completion: GlobalData Read more
Results show potential of J&J’s TAR-210 to transform treatment of bladder cancer with FGFR alterations Read more
PROSEEK study shows no treatment benefit of Vodobatinib in patients with early Parkinson’s Disease Read more